Investor profile
Celesta Capital
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Celesta Capital is a global deep tech venture capital firm that invests in brilliance at the forefront of science and engineering, targeting companies that enable mass adoption of emerging technologies, radically improve health outcomes, and transform large industries. The firm focuses on three primary use cases: (1) platforms enabling mass adoption of emerging technologies — including next-gen semiconductors, intelligent hardware systems, AI applications, and cloud infrastructure; (2) bioconvergence innovations at the intersection of high tech and biotech — spanning drug discovery, diagnostics, imaging, and therapeutics; and (3) technologies transforming large industries with low legacy tech adoption, such as construction, retail, agriculture, healthcare, and education. Celesta prides itself on being an operator-led, hands-on partner that contributes intellectual capital — deep C-suite experience, serial entrepreneurship, and full-stack technical expertise — not just financial capital, to help founders scale from whiteboard to world stage.
Notable quotes
“We believe that when we invest, the most important ingredient that Celesta can bring to the partnership between us and the entrepreneurs is our intellectual capital. Anyone can provide financial capital – what we bring is the experience and knowledge of what it takes to develop successful products, teams, and businesses.”
“Celesta has been doing deep tech from day one, and we were always investors in hardware and semiconductors and systems and the like. And so in a way, we're thrilled that what we do is literally at the core of what the opportunities are and what people want to do.”
“By the time you come to us to raise a Series A, you need to have a really good sense for: once you're done building your thing and you have production samples, who's going to buy it, how much are they going to pay for it, what design slot is it going into, what are your margin details.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| SambaNova Systems | Series D | — | — |
| Eliyan | Series B | $60m | — |
| Habana Labs | Series B | — | — |
| Agnikul | Series C | — | 2025-11-22 |
| HiO | Series B | — | — |
| Movandi | Series B | — | — |
| WEKA | Growth | — | — |
| Vayyar Imaging | Series C | — | — |
| Robinhood | Seed | — | — |
| Prellis Biologics | Series A | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Cota Capital | 7 |
| Samsung Catalyst Fund | 4 |
| Intel Capital | 4 |
| Atreides Management | 4 |
| Qualcomm Ventures | 3 |
| SoftBank Vision Fund | 3 |
Fit check
Is Celesta Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit